Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DED”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Not applicableNot Yet RecruitingNCT07369375
What this trial is testing

Efficacy and Safety of VMX Eye Drops for Dry Eye Disease

Who this might be right for
Dry Eye Disease (DED)
VISUfarma SpA 76
Post-approval studies (Phase 4)Study completedNCT06800274
What this trial is testing

Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

Who this might be right for
Allergic ConjunctivitisDry Eye Disease (DED)
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona 134
Testing effectiveness (Phase 2)Study completedNCT03889886
What this trial is testing

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Who this might be right for
Dry Eye
Silk Technologies, Ltd. 305
Testing effectiveness (Phase 2)Study completedNCT04747977
What this trial is testing

To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease

Who this might be right for
Dry Eye
Ocular Therapeutix, Inc. 172
Testing effectiveness (Phase 2)Study completedNCT03652051
What this trial is testing

Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Who this might be right for
Meibomian Gland DysfunctionDry Eye
Azura Ophthalmics 321
Post-approval studies (Phase 4)Not Yet RecruitingNCT06525961
What this trial is testing

ITear Single-center, Open-label, Single-arm Study

Who this might be right for
Dry Eye DiseaseDry Eye SyndromesDry Eye+1 more
The University of Hong Kong 30
Not applicableWithdrawnNCT03286166
What this trial is testing

Single Center, Prospective, Randomized, Controlled, Non-significant Risk

Who this might be right for
Dry Eye
Toyos Clinic
Not applicableStudy completedNCT03874429
What this trial is testing

Efficacy of T2259 in DED

Who this might be right for
Dry Eye Syndromes
Laboratoires Thea 101
Testing effectiveness (Phase 2)UnknownNCT06146881
What this trial is testing

Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia

Who this might be right for
Dry Eye Disease
Indonesia University 70
Large-scale testing (Phase 3)Study completedNCT03108664
What this trial is testing

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)

Who this might be right for
Dry Eye Disease
Sylentis, S.A. 330
Very early researchStudy completedNCT07239128
What this trial is testing

Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus

Who this might be right for
Dry Eye Disease (DED)
University of Seville 160
Post-approval studies (Phase 4)Looking for participantsNCT06655441
What this trial is testing

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

Who this might be right for
Dry Eye Disease (DED)
Southern California College of Optometry at Marshall B. Ketchum University 30
Not applicableNot Yet RecruitingNCT06989827
What this trial is testing

Impact of DED on the Accuracy of Preoperative Keratometry Values in the Calculation of IOL Power for Cataract Surgery.

Who this might be right for
Dry Eye Disease (DED)Cataract
University Hospital Sestre Milosrdnice 100
Not applicableUnknownNCT04485533
What this trial is testing

Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

Who this might be right for
Dry Eye Syndromes
VISUfarma SpA 90
Testing effectiveness (Phase 2)Study completedNCT06244316
What this trial is testing

A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.

Who this might be right for
Dry Eye Disease
Dompé Farmaceutici S.p.A 317
Testing effectiveness (Phase 2)Study completedNCT03418727
What this trial is testing

Dry Eye Disease Study With Brimonidine

Who this might be right for
Dry Eye
Ocugen 84
Testing effectiveness (Phase 2)UnknownNCT06133166
What this trial is testing

The Treatment of Dry Eye in Postmenopausal Women

Who this might be right for
Postmenopausal Women With DED
Changchun GeneScience Pharmaceutical Co., Ltd. 240
Post-approval studies (Phase 4)Not Yet RecruitingNCT07281950
What this trial is testing

Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT)

Who this might be right for
Dry Eye Disease (DED)
Center for Sight Las Vegas 60
Post-approval studies (Phase 4)Study completedNCT07588074
What this trial is testing

Tolerability Comparison of Flarex to Lotemax SM

Who this might be right for
Ocular InflammationKeratoconjunctivitisDry Eye Disease (DED)+4 more
Harrow Inc 40
Not applicableStudy completedNCT06981104
What this trial is testing

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

Who this might be right for
Dry Eye Disease (DED)Asthenopia
Second Affiliated Hospital, School of Medicine, Zhejiang University 60
Load More Results